Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

NVO submits higher-dose Wegovy to EMA, aiming for greater weight loss and stronger defense against rivals in the obesity ...

Danish drugmaker Novo Nordisk is working to bring its blockbuster drug Ozempic to India “as soon as possible", Dr Yan Cai, ...

There’s no such thing as "natural Ozempic." While supplements like psyllium, berberine, and glucomannan are paraded as ...

Considering GLP-1 agonists tend to perform better at higher doses, it remains to be seen if Mounjaro 15 mg would outperform Ozempic 2 mg in a head-to-head trial.

Already approved at a lower dose as Ozempic for treating diabetes, the new 2.4 mg once-weekly formulation – which will be sold as Wegovy – is the first new medicine to be approved in the US ...

ALONG with rapid fat loss, weight loss jabs have been linked to a decrease in muscle mass. But scientists say one injection – ...

As a diabetes patient, always be prepared for your doctor’s visit with a list of detailed, thoughtful questions that can help ...

Terns' late-stage assets target CML & obesity with key data in Q4 2025. Explore their potential in massive markets. Click ...

A naturally occurring compound in olives, elenolic acid, has shown promise as a potential treatment for obesity and type 2 ...

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announced that human study GLP-1-H25-5 which ...